Table 4.

Change in peripheral blood malignant lymphocyte count after 7 days of thalidomide treatment


Patient no.

ALC at baseline, × 109 cells/L

ALC on day 7, × 109 cells/L

% change
1   106.85   114.30   +7  
2   201.30   210.74   +5  
3   73.50   69.70   -5  
4   1.94   1.70   -12  
5   11.00   8.31   -24  
6   39.19   28.78   -27  
7   110.90   67.70   -39  
8   44.34   20.10   -55  
9   123.30   55.80   -55  
10   41.20   18.64   -55  
11   115.20   49.60   -57  
12   33.08   12.69   -62  
13
 
6.71
 
1.07
 
-84
 

Patient no.

ALC at baseline, × 109 cells/L

ALC on day 7, × 109 cells/L

% change
1   106.85   114.30   +7  
2   201.30   210.74   +5  
3   73.50   69.70   -5  
4   1.94   1.70   -12  
5   11.00   8.31   -24  
6   39.19   28.78   -27  
7   110.90   67.70   -39  
8   44.34   20.10   -55  
9   123.30   55.80   -55  
10   41.20   18.64   -55  
11   115.20   49.60   -57  
12   33.08   12.69   -62  
13
 
6.71
 
1.07
 
-84
 

or Create an Account

Close Modal
Close Modal